First-Trimester Follistatin-Like-3 Levels in Pregnancies Complicated by Subsequent Gestational Diabetes Mellitus
Show simple item record
| dc.contributor.author |
Tjoa, May Lee |
|
| dc.contributor.author |
Schneyer, Alan |
|
| dc.contributor.author |
Thadhani, Ravi Ishwar
|
|
| dc.contributor.author |
Powe, Camille Elise
|
|
| dc.contributor.author |
Khankin, Eliyahu
|
|
| dc.contributor.author |
Ye, Jun |
|
| dc.contributor.author |
Ecker, Jeffrey Lawrence
|
|
| dc.contributor.author |
Karumanchi, Subbian Ananth
|
|
| dc.date.accessioned |
2012-02-14T03:21:39Z |
|
| dc.date.issued |
2009 |
|
| dc.identifier.citation |
Thadhani, Ravi, Camille E. Powe, May Lee Tjoa, Eliyahu Khankin, Jun Ye, Jeffrey Ecker, Alan Schneyer, and S. Ananth Karumanchi. 2010. First-Trimester Follistatin-Like-3 Levels in Pregnancies Complicated by Subsequent Gestational Diabetes Mellitus. Diabetes Care 33(3): 664-669. |
en_US |
| dc.identifier.issn |
0149-5992 |
en_US |
| dc.identifier.uri |
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8160880 |
|
| dc.description.abstract |
Objective: To determine whether maternal levels of follistatin-like-3 (FSTL3), an inhibitor of activin and myostatin involved in glucose homeostasis, are altered in the first trimester of pregnancies complicated by subsequent gestational diabetes mellitus (GDM). Research Design and Methods: This was a nested case-control study of subjects enrolled in a prospective cohort of pregnant women with and without GDM (\(\geq\)2 abnormal values on a 100-g glucose tolerance test at ~28 weeks of gestation). We measured FSTL3 levels in serum collected during the first trimester of pregnancy. Logistic regression analyses were used to determine the risk of GDM. Results: Women who developed GDM (n = 37) had lower first-trimester serum levels of FSTL3 compared with women who did not (n = 127) (median 10,789 [interquartile range 7,013-18,939] vs. 30,670 [18,370-55,484] pg/ml, P < 0.001). When subjects were divided into tertiles based on FSTL3 levels, women with the lowest levels demonstrated a marked increase in risk for developing GDM in univariate (odds ratio 11.2 [95% CI 3.6-35.3]) and multivariate (14.0 [4.1-47.9]) analyses. There was a significant negative correlation between first-trimester FSTL3 levels and ~28-week nonfasting glucose levels (r = -0.30, P < 0.001). Conclusions: First-trimester FSTL3 levels are associated with glucose intolerance and GDM later in pregnancy. |
en_US |
| dc.language.iso |
en_US |
en_US |
| dc.publisher |
American Diabetes Association |
en_US |
| dc.relation.isversionof |
doi://10.2337/dc09-1745 |
en_US |
| dc.relation.hasversion |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827528/pdf/ |
en_US |
| dash.license |
LAA |
|
| dc.subject |
cardiovascular and metabolic risk |
en_US |
| dc.title |
First-Trimester Follistatin-Like-3 Levels in Pregnancies Complicated by Subsequent Gestational Diabetes Mellitus |
en_US |
| dc.type |
Journal Article |
en_US |
| dc.description.version |
Version of Record |
en_US |
| dc.relation.journal |
Diabetes Care |
en_US |
| dash.depositing.author |
Thadhani, Ravi Ishwar
|
|
| dc.date.available |
2012-02-14T03:21:39Z |
|
| dash.affiliation.other |
HMS^Medicine-Massachusetts General Hospital |
en_US |
| dash.affiliation.other |
HMS^Health Sciences and Technology |
en_US |
| dash.affiliation.other |
HMS^Medicine- Beth Israel-Deaconess |
en_US |
| dash.affiliation.other |
HMS^Obstetrics Gynecology and Repro. Bio. - BIDMC |
en_US |
| dash.affiliation.other |
HMS^Medicine- Beth Israel-Deaconess |
en_US |
Files in this item
This item appears in the following Collection(s)
Show simple item record
Contact administrator regarding this item (to report mistakes or request changes)